donepezil has been researched along with aluminum chloride in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Jayant, S; Sharma, B; Sharma, BM | 1 |
| Cheng, X; Liu, W; Qiao, Z; Sang, Z; Shi, J; Tan, Z; Wang, K; Wang, Y; Wu, A; Zhao, Y; Zhu, G | 1 |
| Abo El-Magd, NF; Eraky, SM; Ramadan, NM | 1 |
3 other study(ies) available for donepezil and aluminum chloride
| Article | Year |
|---|---|
Protective effect of transient receptor potential vanilloid subtype 1 (TRPV1) modulator, against behavioral, biochemical and structural damage in experimental models of Alzheimer's disease.
Topics: Aluminum Chloride; Aluminum Compounds; Alzheimer Disease; Animals; Benzaldehydes; Brain; Chlorides; Cholinesterase Inhibitors; Disease Models, Animal; Donepezil; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Galactose; Indans; Mice; Neuroprotective Agents; Nootropic Agents; Piperidines; Streptozocin; TRPV Cation Channels | 2016 |
The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Aluminum Chloride; Alzheimer Disease; Amyloid beta-Peptides; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Drug Development; Humans; Ligands; Molecular Structure; Neuroprotective Agents; Oxidative Stress; Peptide Fragments; Structure-Activity Relationship; Zebrafish | 2020 |
Ameliorative effects of bromelain on aluminum-induced Alzheimer's disease in rats through modulation of TXNIP pathway.
Topics: Aluminum; Aluminum Chloride; Alzheimer Disease; Animals; Bromelains; Cell Cycle Proteins; Disease Models, Animal; Donepezil; Phosphatidylinositol 3-Kinases; Rats | 2023 |